The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines

Morosetti, R., Servidei, T., Mirabella, M., Rutella, S. ORCID: 0000-0003-1970-7375, Mangiola, A., Maira, G., Mastrangelo, R. and Koeffler, H., 2004. The PPARγ ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. International Journal of Oncology, 25 (2), pp. 493-502. ISSN 1019-6439

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	International Journal of Oncology
Creators:	Morosetti, R., Servidei, T., Mirabella, M., Rutella, S., Mangiola, A., Maira, G., Mastrangelo, R. and Koeffler, H.
Publisher:	Spandidos
Date:	August 2004
Volume:	25
Number:	2
ISSN:	1019-6439
Identifiers:	Number Type 10.3892/ijo.25.2.493 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	28 Sep 2016 15:38
Last Modified:	09 Jun 2017 14:06
URI:	https://irep.ntu.ac.uk/id/eprint/28686

Actions (login required)

Edit View

Views

Downloads